You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Bullous Diseases
 •Pemphigus
 •Photosensitivity Disorders
 •Pemphigoid
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

VIGNETTES
Clinical Evidence of an Intermolecular Epitope Spreading in a Patient With Pemphigus Foliaceus Converting Into Bullous Pemphigoid

Jennifer D. Peterson, MD; Agnes J. Chang, MD; Lawrence S. Chan, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Pemphigus foliaceus and bullous pemphigoid are 2 distinct forms of autoimmune blistering disorders with unique clinical, histologic, and immunologic features. We describe a patient with pemphigus foliaceus that converted into bullous pemphigoid, providing evidence of clinical intermolecular epitope spreading.

Report of a Case

An 86-year-old African American man presented in 2001 with crusted lesions in his scalp and widespread erosions involving the face, back, chest, abdomen, and extremities. No intact blisters were observed; the mucous membranes were uninvolved. Histopathologic analysis revealed acantholysis and intraepidermal blister formation within the upper epidermis, consistent with pemphigus foliaceus (Figure). Direct immunofluorescence showed epithelial cell surface IgG and C3 deposits without any skin basement membrane deposition; an indirect immunofluorescence study was not performed. The patient was treated for the next 1.5 years with prednisone (up to 60 mg/d) and azathioprine (up to 150 mg twice . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Childhood Bullous Pemphigoid: Clinical and Immunological Findings in a Series of 4 Cases
Maria Isabel Martinez-De Pablo, Maria Antonia González-Enseñat, Asunción Vicente, Montserrat Gilaberte, and José Manuel Mascaró, Jr
Arch Dermatol. 2007;143(2):215-220.
ABSTRACT | FULL TEXT  

The Role of IgE Anti–Basement Membrane Zone Autoantibodies in Bullous Pemphigoid
David T. Woodley
Arch Dermatol. 2007;143(2):249-250.
EXTRACT | FULL TEXT  

Coexistence of Pemphigus Foliaceus and Bullous Pemphigoid: Demonstration of Autoantibodies That Bind to Both the Pemphigus Foliaceus Antigen Complex and the Bullous Pemphigoid Antigen
Neil J. Korman, John R. Stanley, and David T. Woodley
Arch Dermatol. 1991;127(3):387-390.
ABSTRACT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.